- Location
molecular assay
"-
Foodborne Illness Outbreaks Result When Two or More Persons Develop Similar Symptoms
Jan 9, 2014Foodborne illness outbreaks result when two or more persons develop similar symptoms of illness (gastroenteritis) after eating a common food, or become ill after consuming food from a common source. Such events occur relatively frequently ...
Tags: Foodborne Illness, Food Safety, Food
-
Quidel Has Completed The Acquisition of Biohelix Corporation
May 8, 2013Quidel Corporation, a US-based virology assays and molecular diagnostic systems provider has completed the acquisition of BioHelix Corporation. As per the terms of the deal, Quidel will pay $10m in cash to the shareholders of BioHelix and ...
-
Quidel Molecular Direct HSV 1+2/VZV Assay Is Granted CE Mark for Quidel
Mar 28, 2013US-based diagnostic testing solutions provider Quidel has gained CE Mark for its Quidel Molecular Direct HSV 1+2/VZV assay for the differentiation and detection of herpes simplex viruses 1 and 2 (HSV 1+2) and varicella-zoster virus (VZV) in ...
Tags: CE Mark, Molecular Direct, diagnostic testing solutions
-
Life Technologies Has Introduced a New Real-Time PCR Based Molecular Diagnostic Instrument
Dec 17, 2012Life Technologies has introduced a new real-time PCR based molecular diagnostic instrument for diagnostic use in the Europe. The Applied Biosystems QuantStudio Dx instrument, which is released with Quidel Molecular assay for C. difficile, ...
Tags: molecular diagnostic instrument, diagnostic instrument, real-time PCR
-
Quidel Has Gained CE Mark
Dec 4, 2012Quidel has gained CE mark for the Quidel Molecular Direct C difficile Tox A/B assay to detect toxigenic Clostridium difficile bacterial DNA. The Quidel Molecular Direct C difficile Tox A/B assay kits consist of an extraction-free, ...
Tags: Quidel, Quidel Molecular Direct C difficile Tox A/B assay kits, CE mark
-
NeoGenomics Has Launched The First Molecular Assay
Nov 30, 2012The cancer genetic testing services provider, NeoGenomics has launched the first molecular assay, NeoType CLL for clinical use in the US, which detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1). The assay will offer ...
Tags: molecular assay, clinical research, clinical development
